A carregar...
CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data
Breast cancer patients with residual disease after neoadjuvant chemotherapy and surgery may benefit from additional anti-cancer therapies. Capecitabine, an oral antimetabolite and prodrug of 5-Flurouracil, has been approved for treating metastatic breast cancer. One randomized clinical trial (CREATE...
Na minha lista:
| Publicado no: | NPJ Breast Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519731/ https://ncbi.nlm.nih.gov/pubmed/28758147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0029-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|